Aarti Surfactants Ltd. Share Price

Aarti Drugs: Diversified Portfolio Supports Growth Prospects

Aarti Drugs continues to strengthen its position in the pharmaceutical and specialty chemicals segment, supported by a diversified product portfolio and established manufacturing capabilities. The company operates across APIs, formulations, specialty chemicals and pharmaceutical intermediates, serving both domestic and international markets. Focus on product development, capacity expansion and operational efficiency remains important for sustaining growth. Export opportunities and increasing demand for pharmaceutical ingredients can provide additional avenues, while raw-material prices, regulatory requirements, pricing pressure and global market conditions remain key factors to monitor. Continued investment in manufacturing capabilities and a broader product mix could help the company strengthen its competitive position over the longer term. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link visit website www dot investmentcure dot com *****

See More

High-Growth Small-Cap Stocks to Track for the Next Few Years

High-Growth Small-Cap Stocks to Track for the Next Few Years Small-Cap Growth Watchlist

1. E2E Networks 2. MTAR Technologies 3. Syrma SGS Technology 5. HFCL 6. Deep Industries 7. Apcotex Industries 8. Fineotex Chemical 9. Beta Drugs 10. Tatva Chintan Pharma Chem 11. Balaji Amines 12. Aarti Surfactants 13. Aarti Industries 14. Craftsman Automation 15. Prataap Snacks 16. Sportking India 17. CleanMax Enviro Energy 18. Sasken Technologies 19. Sakar Healthcare 20. Blue Dart Express 21. ACME Solar Holdings #MultibaggerStocks #StocksToWatch #WealthCreation #NSE #BSE #LongTermInvesting

See More

Aarti Surfactants shares hit the 20% upper circuit

In contrast,

actants shares hit the 20% upper circuit, closing significantly higher (around Rs 459) after explosive profit growth. Consolidated net profit soared 358% YoY to Rs 3.66 crore from Rs 0.80 crore, while revenue climbed 27.65% YoY to Rs 207.79 crore, reflecting improved margins and operational efficiency in the surfactants segment.

See More

Aarti Surfactants Ltd – SWOT Analysis

Strengths Established Surfactant Manufacturer: Focus on specialty surfactants used in home & personal care, agrochemicals, and industrial applications. Strong Parentage: Part of the Aarti Group, providing credibility, technical know-how, and governance support. Diverse End-Use Industries: Exposure to FMCG, agrochemicals, textiles, and industrial cleaning. Export Presence: Supplies to domestic and international customers. R&D Capability: Customised formulations and specialty product development. Weaknesses Raw Material Dependence: Sensitive to prices of ethylene oxide and petrochemical derivatives. Moderate Scale: Smaller compared to large global specialty chemical peers. Margin Volatility: Input-cost fluctuations impact profitability. Customer Concentration Risk: Dependence on a limited set of large clients. Working Capital Intensity: Inventory and receivable management critical. Opportunities Rising FMCG Consumption: Growth in home & personal care demand in India. Specialty Chemical Shift: Moving toward higher-margin, value-added surfactants. Import Substitution: Opportunities due to global supply-chain diversification. New Applications: Expanding use of surfactants in agro and industrial processes. Threats Raw Material Price Volatility: Petrochemical input fluctuations. Intense Competition: From domestic specialty players and multinational companieS. Global Demand Slowdown: Affects export volumes. Currency Risk: Exchange-rate volatility impacts export realisations. Disclaimer Disclaimer: This analysis is provided solely for educational and informational purposes and should not be construed as investment advice or a recommendation to buy, sell, or hold any security. Stock-market investments are subject to market risks. Investors are advised to consult a SEBI-registered investment advisor before making any investment decision. Registration Number: INH000013174

See More